Concentrix financials
$24.88−2.24%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 May 31 | Q1 '26 Feb 28 | Q4 '25 Nov 30 | Q3 '25 Aug 31 | Q2 '25 May 31 | Q1 '25 Feb 28 | Q4 '24 Nov 30 | Q3 '24 Aug 31 | Q2 '24 May 31 | Q1 '24 Feb 29 | Q4 '23 Nov 30 | Q3 '23 Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.46B | $2.50B | $2.55B | $2.48B | $2.42B | $2.37B | $2.45B | $2.39B | $2.38B | $2.40B | $2.23B | $1.63B |
| Gross profit | $823.3M | $849.7M | $876.0M | $855.0M | $848.1M | $855.9M | $870.6M | $864.2M | $857.6M | $856.5M | $822.9M | $593.7M |
| Gross margin | 33.4% | 34.0% | 34.3% | 34.4% | 35.1% | 36.1% | 35.6% | 36.2% | 36.0% | 35.6% | 36.9% | 36.4% |
| Operating income | $95.4M | $118.6M | -$1.38B | $147.0M | $148.3M | $168.9M | $144.5M | $153.2M | $150.2M | $148.4M | $180.4M | $162.3M |
| Net income | $52.5M | $21.6M | -$1.47B | $83.9M | $40.1M | $70.3M | $111.0M | $16.1M | $64.3M | $50.1M | $63.5M | $77.6M |
| Net margin | 2.1% | 0.9% | −57.7% | 3.4% | 1.7% | 3.0% | 4.5% | 0.7% | 2.7% | 2.1% | 2.8% | 4.8% |
| Diluted EPS | $0.86 | $0.33 | $-23.82 | $1.34 | $0.63 | $1.04 | $1.72 | $0.25 | $0.98 | $0.76 | $1.02 | $1.49 |
| EBITDA | $255.5M | $277.9M | $311.2M | $315.5M | $313.7M | $329.6M | $313.3M | $329.4M | $327.1M | $332.5M | $180.4M | $240.0M |
| Operating cash flow | $257.9M | -$83.2M | $344.2M | $224.8M | $236.5M | $1.4M | $284.4M | $191.6M | $238.3M | -$46.9M | $229.3M | $211.4M |
| Free cash flow | $209.7M | -$137.1M | $281.2M | $159.7M | $180.7M | -$49.2M | $224.5M | $128.9M | $178.3M | -$102.9M | $164.4M | $167.5M |
| Diluted shares | 60.9M | 61.3M | 61.9M | 62.7M | 63.4M | 64.1M | 64.4M | 64.7M | 65.3M | 65.8M | 62.0M | 51.2M |
Balance sheet
| Period end | May 31 | Feb 28 | Nov 30 | Aug 31 | May 31 | Feb 28 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $255.6M | $222.7M | $327.3M | $350.3M | $342.8M | $308.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.58B | $4.75B | $4.64B | $4.83B | $4.89B | $4.90B |
| Total assets | $10.51B | $10.67B | $10.76B | $12.41B | $12.40B | $11.90B |
| Total liabilities | $7.81B | $7.89B | $8.02B | $8.07B | $8.12B | $7.86B |
| Shareholders' equity | $2.70B | $2.79B | $2.74B | $4.34B | $4.28B | $4.03B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology